395099-09-9

Basic information

• Product Name: Methanone, [2-amino-5-(phenylmethoxy)phenyl]phenyl-
• CAS NO: 395099-09-9
• Molecular Formula: C20H17NO2
• Molecular Weight: 303.36
• Mol File: 395099-09-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Methanone, [2-amino-5-(phenylmethoxy)phenyl]phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Methanone, [2-amino-5-(phenylmethoxy)phenyl]phenyl-(395099-09-9)
• EPA Substance Registry System: Methanone, [2-amino-5-(phenylmethoxy)phenyl]phenyl-(395099-09-9)

Safety Data

• Hazardous Substances Data: 395099-09-9(Hazardous Substances Data)

Upstream product

• 109-99-9 tetrahydrofuran 
• 1362019-60-0 C₂₀H₁₇NO₄ 
• 1362019-61-1 C₂₀H₁₅NO₄ 
• 100-39-0 benzyl bromide 
• 58662-54-7 5-benzyloxy-2-nitrobenzaldehyde 
• 42454-06-8 2-nitro-5-hydroxybenzaldehyde 

Downstream Products

• 1362019-82-6 (2R,3S,4R)-ethyl 6-(benzyloxy)-2-methyl-4-phenyl-1,2,3,4-tetrahydroquinoline-3-carboxylate 

Relevant articles and documents

Step-economical synthesis of tetrahydroquinolines by asymmetric relay catalytic Friedlaender condensation/transfer hydrogenation

Two steps in one reaction: The title relay reaction relies on a combination of an achiral Lewis acid and a chiral Bronsted acid (B-H in the scheme). This one-pot method provides access to tetrahydroquinoline derivatives with multiple continuous stereogeni

Methods for treating an inflammatory condition or inhibiting JNK

This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R1, R2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.